VTRS Q2 Earnings Beat, Revenues Rise 5% as Greater China Sales JumpZacks Investment Research • 08/06/26
Compared to Estimates, Viatris (VTRS) Q2 Earnings: A Look at Key MetricsZacks Investment Research • 08/06/26
Viatris (VTRS) Q2 Earnings on the Horizon: Analysts' Insights on Key Performance MeasuresZacks Investment Research • 08/05/26
Viatris Receives U.S. FDA Approval for Gwyn Lo™, a Once-Weekly Contraceptive PatchPRNewsWire • 07/29/26
Trump's generic drug tariffs: What they could mean for medicine prices, manufacturers and supplyCNBC • 07/22/26
Viatris Announces Positive Top-Line Results from Phase 3 Study of VR-205 in Japanese Adults with Primary Immunoglobulin A NephropathyPRNewsWire • 06/29/26